BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 28322746)

  • 1. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes.
    Janssens R; Mortier A; Boff D; Ruytinx P; Gouwy M; Vantilt B; Larsen O; Daugvilaite V; Rosenkilde MM; Parmentier M; Noppen S; Liekens S; Van Damme J; Struyf S; Teixeira MM; Amaral FA; Proost P
    Biochem Pharmacol; 2017 May; 132():92-101. PubMed ID: 28322746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural nitration of CXCL12 reduces its signaling capacity and chemotactic activity in vitro and abrogates intra-articular lymphocyte recruitment in vivo.
    Janssens R; Mortier A; Boff D; Vanheule V; Gouwy M; Franck C; Larsen O; Rosenkilde MM; Van Damme J; Amaral FA; Teixeira MM; Struyf S; Proost P
    Oncotarget; 2016 Sep; 7(38):62439-62459. PubMed ID: 27566567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxynitrite Exposure of CXCL12 Impairs Monocyte, Lymphocyte and Endothelial Cell Chemotaxis, Lymphocyte Extravasation
    Janssens R; Boff D; Ruytinx P; Mortier A; Vanheule V; Larsen O; Daugvilaite V; Rosenkilde MM; Noppen S; Liekens S; Schols D; De Meester I; Opdenakker G; Struyf S; Teixeira MM; Amaral FA; Proost P
    Front Immunol; 2018; 9():1933. PubMed ID: 30233568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling.
    Metzemaekers M; Mortier A; Janssens R; Boff D; Vanbrabant L; Lamoen N; Van Damme J; Teixeira MM; De Meester I; Amaral FA; Proost P
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin.
    Saaber F; Schütz D; Miess E; Abe P; Desikan S; Ashok Kumar P; Balk S; Huang K; Beaulieu JM; Schulz S; Stumm R
    Cell Rep; 2019 Feb; 26(6):1473-1488.e9. PubMed ID: 30726732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells.
    Christopherson KW; Hangoc G; Broxmeyer HE
    J Immunol; 2002 Dec; 169(12):7000-8. PubMed ID: 12471135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4.
    Struyf S; Noppen S; Loos T; Mortier A; Gouwy M; Verbeke H; Huskens D; Luangsay S; Parmentier M; Geboes K; Schols D; Van Damme J; Proost P
    J Immunol; 2009 Jan; 182(1):666-74. PubMed ID: 19109200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing by CD26/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1alpha.
    Proost P; Struyf S; Schols D; Durinx C; Wuyts A; Lenaerts JP; De Clercq E; De Meester I; Van Damme J
    FEBS Lett; 1998 Jul; 432(1-2):73-6. PubMed ID: 9710254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comodulation of CXCR4 and CD26 in human lymphocytes.
    Herrera C; Morimoto C; Blanco J; Mallol J; Arenzana F; Lluis C; Franco R
    J Biol Chem; 2001 Jun; 276(22):19532-9. PubMed ID: 11278278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMD3100 and CD26 modulate mobilization, engraftment, and survival of hematopoietic stem and progenitor cells mediated by the SDF-1/CXCL12-CXCR4 axis.
    Broxmeyer HE; Hangoc G; Cooper S; Campbell T; Ito S; Mantel C
    Ann N Y Acad Sci; 2007 Jun; 1106():1-19. PubMed ID: 17360804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical Chemokine Receptor 3 "Senses" CXC Chemokine Receptor 4 Activation Through GPCR Kinase Phosphorylation.
    Schafer CT; Chen Q; Tesmer JJG; Handel TM
    Mol Pharmacol; 2023 Oct; 104(4):174-186. PubMed ID: 37474305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapeutic agents attenuate CXCL12-mediated migration of colon cancer cells by selecting for CXCR4-negative cells and increasing peptidase CD26.
    Cutler MJ; Lowthers EL; Richard CL; Hajducek DM; Spagnuolo PA; Blay J
    BMC Cancer; 2015 Nov; 15():882. PubMed ID: 26552750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation.
    Jungraithmayr W; De Meester I; Matheeussen V; Baerts L; Arni S; Weder W
    Eur J Cardiothorac Surg; 2012 May; 41(5):1166-73. PubMed ID: 22219460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
    Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S
    Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.
    Proost P; Menten P; Struyf S; Schutyser E; De Meester I; Van Damme J
    Blood; 2000 Sep; 96(5):1674-80. PubMed ID: 10961862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12.
    Del Molino Del Barrio I; Wilkins GC; Meeson A; Ali S; Kirby JA
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30441765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An angiotensin-converting enzyme inhibitor modulates stromal-derived factor-1 through CD26/dipeptidyl peptidase IV to inhibit laser-induced choroidal neovascularization.
    Li H; Wang YS
    Mol Vis; 2013; 19():1107-21. PubMed ID: 23734079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV.
    Narducci MG; Scala E; Bresin A; Caprini E; Picchio MC; Remotti D; Ragone G; Nasorri F; Frontani M; Arcelli D; Volinia S; Lombardo GA; Baliva G; Napolitano M; Russo G
    Blood; 2006 Feb; 107(3):1108-15. PubMed ID: 16204308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis.
    Busso N; Wagtmann N; Herling C; Chobaz-Péclat V; Bischof-Delaloye A; So A; Grouzmann E
    Am J Pathol; 2005 Feb; 166(2):433-42. PubMed ID: 15681827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface peptidase CD26/DPPIV mediates G-CSF mobilization of mouse progenitor cells.
    Christopherson KW; Cooper S; Broxmeyer HE
    Blood; 2003 Jun; 101(12):4680-6. PubMed ID: 12576320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.